Insulin glargine use and short-term incidence of breast cancer — a four-year population-based observation

Rickard LjungNational Board of Health and Welfare, Stockholm, Sweden;Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden;Equity and Health Policy, Department of Public Health Sciences, Karolinska Institutet, Stockholm, SwedenCorrespondence[email protected]

Mats TalbäckNational Board of Health and Welfare, Stockholm, Sweden

Bengt HaglundNational Board of Health and Welfare, Stockholm, Sweden

Junmei Miao JonassonDivision of Clinical Cancer Epidemiology, Department of Oncology, The Sahlgrenska Academy, Onkologiskt Centrum, Gothenburg, Sweden;Division of Clinical Cancer Epidemiology, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden;National Diabetes Register, Register Center, Västra Götaland Region, Sweden

Soffia GudbjörnsdòttirDiabetes Centre, Sahlgrenska University Hospital, Gothenburg, Sweden;Nordic School of Public Health, Gothenburg, Sweden;National Diabetes Register, Register Center, Västra Götaland Region, Sweden

Gunnar SteineckDivision of Clinical Cancer Epidemiology, Department of Oncology, The Sahlgrenska Academy, Onkologiskt Centrum, Gothenburg, Sweden

Click to increase image sizeClick to decrease image size

Acknowledgements

Supported by Astrid and David Hagelén Foundation, Swedish Research Council, Swedish Diabetes Foundation, AGFOND, Konrad and Helfrid Johansson Foundation, VINNMER and VINNOVA. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Declaration of interest: RL and BH are also members of another international research collaboration that has received a grant from Sanofi-Aventis to study the association between insulin glargine and cancer.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Insulin glargine use and short-term incidence of breast cancer — a four-year population-based observation

Information for

Open access

Opportunities

Help and information

Insulin glargine use and short-term incidence of breast cancer — a four-year population-based observation

Acknowledgements

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature